These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10708941)

  • 1. Long-term survival in Hodgkin's disease patients. A comparison of relative survival in patients in trials and those recorded in population-based cancer registries.
    Roy P; Vaughan Hudson G; Vaughan Hudson B; Esteve J; Swerdlow AJ
    Eur J Cancer; 2000 Feb; 36(3):384-9. PubMed ID: 10708941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late mortality in young BNLI patients cured of Hodgkin's disease.
    Vaughan Hudson B; Vaughan Hudson G; Linch DC; Anderson L
    Ann Oncol; 1994; 5 Suppl 2():65-6. PubMed ID: 8204522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger.
    Ng AK; Bernardo MP; Weller E; Backstrand KH; Silver B; Marcus KC; Tarbell NJ; Friedberg J; Canellos GP; Mauch PM
    J Clin Oncol; 2002 Apr; 20(8):2101-8. PubMed ID: 11956271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group.
    Kreissl S; Mueller H; Goergen H; Mayer A; Brillant C; Behringer K; Halbsguth TV; Hitz F; Soekler M; Shonukan O; Rueffer JU; Flechtner HH; Fuchs M; Diehl V; Engert A; Borchmann P;
    Lancet Oncol; 2016 Oct; 17(10):1453-1462. PubMed ID: 27612583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
    Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
    Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome in Hodgkin's disease: a 20-year cohort of patients.
    Ranaghan L; Markey GM; Morris TC
    Ulster Med J; 1998 Nov; 67(2):91-8. PubMed ID: 9885544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival of Hodgkin's patients in south-east Netherlands since 1972.
    van Spronsen DJ; Dijkema IM; Vrints LW; Hofstra G; Crommelin MA; Erdkamp FL; Coebergh JW; Breed WP
    Eur J Cancer; 1997 Mar; 33(3):436-41. PubMed ID: 9155529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Survival of Patients With Hodgkin Lymphoma Over 4 Decades: Experience of the British National Lymphoma Investigation (BNLI) With 6834 Patients.
    Kwan A; Chadwick N; Hancock B
    Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):108-119. PubMed ID: 28027894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term cause-specific mortality of patients treated for Hodgkin's disease.
    Aleman BM; van den Belt-Dusebout AW; Klokman WJ; Van't Veer MB; Bartelink H; van Leeuwen FE
    J Clin Oncol; 2003 Sep; 21(18):3431-9. PubMed ID: 12885835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Completeness of cancer registration in England and Wales: an assessment based on 2,145 patients with Hodgkin's disease independently registered by the British National Lymphoma Investigation.
    Swerdlow AJ; Douglas AJ; Vaughan Hudson G; Vaughan Hudson B
    Br J Cancer; 1993 Feb; 67(2):326-9. PubMed ID: 8431361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
    van Leeuwen FE; Klokman WJ; Hagenbeek A; Noyon R; van den Belt-Dusebout AW; van Kerkhoff EH; van Heerde P; Somers R
    J Clin Oncol; 1994 Feb; 12(2):312-25. PubMed ID: 8113838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry.
    van Spronsen DJ; Janssen-Heijnen ML; Lemmens VE; Peters WG; Coebergh JW
    Eur J Cancer; 2005 May; 41(7):1051-7. PubMed ID: 15862755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups.
    Allemani C; Sant M; De Angelis R; Marcos-Gragera R; Coebergh JW;
    Cancer; 2006 Jul; 107(2):352-60. PubMed ID: 16770772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
    Urquhart A; Berg R
    Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival from malignant digestive endocrine tumors in England and Wales: a population-based study.
    Lepage C; Rachet B; Coleman MP
    Gastroenterology; 2007 Mar; 132(3):899-904. PubMed ID: 17383419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR).
    Nachbaur D; Greinix HT; Koller E; Krieger O; Linkesch W; Kasparu H; Pober M; Hinterberger W; Hausmaninger H; Heistinger M; Ulsperger E; Karlhuber S; Schwinger W; Lindner B
    Ann Hematol; 2005 Jul; 84(7):462-73. PubMed ID: 15726362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials.
    von Tresckow B; Kreissl S; Goergen H; Bröckelmann PJ; Pabst T; Fridrik M; Rummel M; Jung W; Thiemer J; Sasse S; Bürkle C; Baues C; Diehl V; Engert A; Borchmann P;
    Lancet Haematol; 2018 Oct; 5(10):e462-e473. PubMed ID: 30290903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin's disease in patients with HIV infection and in the general population: comparison of clinicopathological features and survival.
    Errante D; Zagonel V; Vaccher E; Serraino D; Bernardi D; Sorio R; Trovò M; Carbone A; Monfardini S; Tirelli U
    Ann Oncol; 1994; 5 Suppl 2():37-40. PubMed ID: 8204518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.